BioArctic AB (OSTO:BIOA B)
kr 238.4 5 (2.14%) Market Cap: 21.06 Bil Enterprise Value: 20.57 Bil PE Ratio: 0 PB Ratio: 21.21 GF Score: 55/100

Full Year 2018 BioArctic AB Earnings Call Transcript

Feb 14, 2019 / 08:30AM GMT
Release Date Price: kr97.75 (+2.79%)
Operator

Ladies and gentlemen, welcome to the BioArctic Q4 2018 report. Today, I'm pleased to present CEO, Gunilla Osswald; and CFO, Jan Mattsson. (Operator Instructions) Speakers, please begin your meeting.

Gunilla Osswald;publ;President;CEO
BioArctic AB

()-&

Thank you so much, and welcome to the full year report of BioArctic from 2018. I'm Gunilla Osswald, and I'm the CEO of BioArctic, and I will share the presentation here today with our CFO, Jan Mattsson.

Next slide, please. This is our disclaimer, and next slide again, please. So BioArctic is focusing on 3 areas where there is a huge unmet medical need: Alzheimer's disease, Parkinson's disease and complete spinal cord injuries.

In Alzheimer's disease and Parkinson's disease today, there are only symptomatic treatments available and we focus on disease-modifying treatment that will affect the underlying disease. Alzheimer's disease and Parkinson's disease are huge and there is a growing market since the population is getting older and older.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot